Azuma Y et al. |
Possible involvement of p38 in mechanisms underlying acceleration of proliferation by 15-deoxy-Delta(12,14)-prostaglandin J2 and the precursors in leukemia cell line THP-1. |
2004 |
J. Pharmacol. Sci. |
pmid:15037811
|
Ayabe S et al. |
Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor. |
2013 |
J. Pharmacol. Sci. |
pmid:23538675
|
Jin YR et al. |
Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade. |
2007 |
J. Pharmacol. Sci. |
pmid:17951980
|
Narumiya S et al. |
Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. |
1987 |
J. Pharmacol. Exp. Ther. |
pmid:3302206
|
Nagira Y et al. |
Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:26945085
|
Almishri W et al. |
Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15590767
|
van den Brule S et al. |
The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice. |
2010 |
J. Pharmacol. Exp. Ther. |
pmid:20719937
|
Hattori Y and Levi R |
Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. |
1986 |
J. Pharmacol. Exp. Ther. |
pmid:3012066
|
Sharif NA et al. |
Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8819509
|
Sharif NA et al. |
Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10772998
|
Regal JF |
Role of arachidonate metabolites in C5a-induced bronchoconstriction. |
1988 |
J. Pharmacol. Exp. Ther. |
pmid:2841450
|
Pettipher R et al. |
Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22106101
|
Hernandez JM and Janssen LJ |
Thromboxane prostanoid receptor activation amplifies airway stretch-activated contractions assessed in perfused intact bovine bronchial segments. |
2011 |
J. Pharmacol. Exp. Ther. |
pmid:21768224
|
Peters SP et al. |
Mediator release from human lung under conditions of reduced oxygen tension. |
1986 |
J. Pharmacol. Exp. Ther. |
pmid:2425080
|
Lacal PM et al. |
Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection. |
1994 |
J. Pharmacol. Exp. Ther. |
pmid:7965770
|
Lacal PM et al. |
Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein. |
1994 |
J. Pharmacol. Exp. Ther. |
pmid:7965771
|
Kriseman T et al. |
Analysis of airway responses to A23187 in the cat. |
1986 |
J. Pharmacol. Exp. Ther. |
pmid:3095538
|
Charlesworth EN et al. |
Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1382132
|
Majewska MD and Chuang DM |
Benzodiazepines enhance the muscimol-dependent activation of phospholipase A2 in glioma C6 cells. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:2857784
|
Napimoga MH et al. |
15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:17928570
|
Shiraishi Y et al. |
Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15528449
|
Monneret G et al. |
Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15388786
|
Ellis JL and Undem BJ |
Antigen-induced enhancement of noncholinergic contractile responses to vagus nerve and electrical field stimulation in guinea pig isolated trachea. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1323657
|
Undem BJ and Adams GK |
An analysis of the functional interactions of selected contractile agonists in the guinea pig isolated trachea. |
1988 |
J. Pharmacol. Exp. Ther. |
pmid:2839671
|
Narumiya S and Fukushima M |
Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. |
1986 |
J. Pharmacol. Exp. Ther. |
pmid:3772804
|
Narumiya S et al. |
Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. |
1986 |
J. Pharmacol. Exp. Ther. |
pmid:3772805
|
Arakida Y et al. |
In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808690
|
Tajima T et al. |
Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18492946
|
Underwood DC et al. |
Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig. |
1994 |
J. Pharmacol. Exp. Ther. |
pmid:8301572
|
Weichman BM et al. |
SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro. |
1984 |
J. Pharmacol. Exp. Ther. |
pmid:6582266
|
Zhang XC et al. |
Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17483291
|
Papaliodis D et al. |
Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18784348
|
Rangachari PK et al. |
Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7473146
|
Undem BJ et al. |
Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. |
1988 |
J. Pharmacol. Exp. Ther. |
pmid:2459368
|
Spannhake EW et al. |
Influence of mediators of anaphylaxis on collateral ventilation and the lung periphery of the dog. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3860642
|
Sugimoto H et al. |
An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12649388
|
Casolaro V et al. |
Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. |
1993 |
J. Pharmacol. Exp. Ther. |
pmid:7505332
|
Ohno K et al. |
Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells. |
1988 |
J. Pharmacol. Exp. Ther. |
pmid:3361448
|
Kim EJ et al. |
Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12966153
|
Woodward DF et al. |
Thromboxane A2-mimetics are potent microvascular permeability factors in the conjunctiva. |
1990 |
J. Pharmacol. Exp. Ther. |
pmid:2213558
|
Shichijo M et al. |
Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12975488
|
Tachikawa M et al. |
A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22931759
|
Hata AN et al. |
Expression and molecular pharmacology of the mouse CRTH2 receptor. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12721327
|
Leduc M et al. |
Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:19584306
|
Eguchi N et al. |
Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1527717
|
Hewson CA et al. |
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22160268
|
Peters SP et al. |
Effect of prostaglandin D2 in modulating histamine release from human basophils. |
1984 |
J. Pharmacol. Exp. Ther. |
pmid:6198512
|
Stier CT et al. |
Renal response to 9 alpha, 11 beta-prostaglandin F2 in the rat. |
1987 |
J. Pharmacol. Exp. Ther. |
pmid:3479549
|
Yu R et al. |
Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. |
2011 |
J. Pharmacol. Exp. Ther. |
pmid:21865441
|
Shimomura K et al. |
Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15201343
|
Monneret G et al. |
15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12490611
|
Cossette C et al. |
Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17041009
|
Raman P et al. |
15-Deoxy-Δ¹²,¹â´-prostaglandin Jâ‚‚-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22700433
|
Minami T et al. |
Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8819497
|
Yokotani K et al. |
Sympathoadrenomedullary system mediation of the prostaglandin E2-induced central inhibition of gastric acid output in rats. |
1988 |
J. Pharmacol. Exp. Ther. |
pmid:3422095
|
Ko FN et al. |
Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation. |
1996 |
J. Pharm. Pharmacol. |
pmid:8794990
|
Bhattacharya SK et al. |
Effect of centrally administered prostaglandin D2 and some prostaglandin synthesis inhibitors on carrageenan-induced paw oedema in rats. |
1989 |
J. Pharm. Pharmacol. |
pmid:2571705
|
Sharif NA and Davis TL |
Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques. |
2002 |
J. Pharm. Pharmacol. |
pmid:11999132
|
Gambero A and Gomes JC |
Pharmacological antagonism of Anchietia salutaris extracts on the contraction induced by prostaglandin D2 and U46619 in guinea-pig lung parenchymal strips. |
1998 |
J. Pharm. Pharmacol. |
pmid:9877316
|
Guh JH et al. |
Antiplatelet effect of gingerol isolated from Zingiber officinale. |
1995 |
J. Pharm. Pharmacol. |
pmid:7791032
|
Bhattacharya SK and Parmar SS |
Prostaglandin D2-induced potentiation of hexobarbitone hypnosis in rats: role of 5-hydroxytryptamine. |
1985 |
J. Pharm. Pharmacol. |
pmid:2868104
|
Bhattacharya SK and Rao PJ |
Prostaglandin D2-induced catalepsy in rats: role of 5-hydroxytryptamine. |
1987 |
J. Pharm. Pharmacol. |
pmid:2890744
|
Mendieta CF et al. |
Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. |
1985 |
J. Periodontol. |
pmid:3919173
|
Siddhivarn C et al. |
Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line. |
2007 |
J. Periodont. Res. |
pmid:17760815
|
Siddhivarn C et al. |
Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line. |
2006 |
J. Periodont. Res. |
pmid:16499711
|
Ford WD et al. |
Pulmonary hypertension in lambs with congenital diaphragmatic hernia: vasodilator prostaglandins, isoprenaline, and tolazoline. |
1990 |
J. Pediatr. Surg. |
pmid:2352080
|
Soifer SJ et al. |
Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. |
1988 |
J. Pediatr. |
pmid:3162978
|
Mirza RE et al. |
Macrophage PPARγ and impaired wound healing in type 2 diabetes. |
2015 |
J. Pathol. |
pmid:25875529
|
Hokari R et al. |
Increased expression and cellular localization of lipocalin-type prostaglandin D synthase in Helicobacter pylori-induced gastritis. |
2009 |
J. Pathol. |
pmid:19768745
|
Gao T et al. |
Arachidonic acid metabolism to prostaglandin E2, D2, F2alpha, and I2 in the plerocercoid of Spirometra erinaceieuropaei. |
1998 |
J. Parasitol. |
pmid:9920298
|
Zanoni G et al. |
First enantioselective total synthesis of (8S,12R,15S)-prostaglandin J(2). |
2003 |
J. Org. Chem. |
pmid:12895084
|
Zanoni G et al. |
A --> J prostaglandin swap: a new tactic for cyclopentenone prostaglandin synthesis. |
2003 |
J. Org. Chem. |
pmid:12919053
|
Zanoni G et al. |
First total synthesis of JS isoprostane. |
2003 |
J. Org. Chem. |
pmid:12868940
|
Kim NJ et al. |
Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). |
2010 |
J. Org. Chem. |
pmid:20929274
|
Patel P et al. |
Enantio- and stereospecific syntheses of 15(R)-Me-PGD2, a potent and selective DP2-receptor agonist. |
2008 |
J. Org. Chem. |
pmid:18700746
|
Nakagomi T et al. |
Effect of removal of the endothelium on vasocontraction in canine and rabbit basilar arteries. |
1988 |
J. Neurosurg. |
pmid:2895803
|
Rodriguez y Baena R et al. |
Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. |
1989 |
J. Neurosurg. |
pmid:2585083
|
Chattopadhyay N et al. |
Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis. |
2000 |
J. Neurosci. Res. |
pmid:10861801
|
Li Z et al. |
Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? |
2004 |
J. Neurosci. Res. |
pmid:15523637
|
Storer PD et al. |
Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. |
2005 |
J. Neurosci. Res. |
pmid:15723383
|
Smith SA et al. |
Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability. |
2003 |
J. Neurosci. Res. |
pmid:12774315
|
Alvarez-Dolado M et al. |
Retinoic acid and 1,25-dihydroxyvitamin D3 inhibit tenascin-C expression in rat glioma C6 cells. |
1999 |
J. Neurosci. Res. |
pmid:10502285
|
Kim SE et al. |
15-deoxy-Δ¹²,¹ⴠ-prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferator-activated receptor-γ and heme oxygenase-1 in rat hippocampal slices. |
2012 |
J. Neurosci. Res. |
pmid:22487967
|
Lysz TW et al. |
Measurement of prostaglandin biosynthetic capacity in discrete areas of the rabbit hippocampal formation. |
1983 |
J. Neurosci. Res. |
pmid:6580469
|
Mohri I et al. |
Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. |
2006 |
J. Neurosci. |
pmid:16624958
|
Heneka MT et al. |
Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. |
2000 |
J. Neurosci. |
pmid:10995830
|
Lee B et al. |
Prostaglandin D synthase in the prenatal ovine brain and effects of its inhibition with selenium chloride on fetal sleep/wake activity in utero. |
2002 |
J. Neurosci. |
pmid:12097519
|
Taniguchi H et al. |
Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. |
2007 |
J. Neurosci. |
pmid:17442814
|
Terao A et al. |
Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. |
1998 |
J. Neurosci. |
pmid:9698346
|
Mouihate A et al. |
A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. |
2004 |
J. Neurosci. |
pmid:14960602
|
Tan W et al. |
Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons. |
1998 |
J. Neurophysiol. |
pmid:9463448
|
De Nuccio C et al. |
Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. |
2011 |
J. Neuropathol. Exp. Neurol. |
pmid:21937914
|
Bernardo A et al. |
Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. |
2009 |
J. Neuropathol. Exp. Neurol. |
pmid:19535992
|
Rodriguez y Baena R et al. |
A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. |
1988 |
J. Neurol. Sci. |
pmid:3132538
|
Storer PD et al. |
Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. |
2005 |
J. Neuroimmunol. |
pmid:15748950
|
Takayama F et al. |
Possible involvement of aiPLA2 in the phosphatidylserine-containing liposomes induced production of PGE2 and PGD2 in microglia. |
2013 |
J. Neuroimmunol. |
pmid:23850486
|
Zhang F et al. |
Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. |
2010 |
J. Neuroimmunol. |
pmid:19942298
|
Heneka MT et al. |
Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. |
1999 |
J. Neuroimmunol. |
pmid:10695726
|
Froldi M et al. |
Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. |
1992 |
J. Neuroimmunol. |
pmid:1315794
|
Raikwar HP et al. |
PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. |
2006 |
J. Neuroimmunol. |
pmid:16844232
|